Ads
-
Related paper
- Farnesoid X Receptor Agonist as a new treatment option for Non-Alcoholic Fatty Liver disease: A Review
- CHANGES IN LIPIDS IN PATIENTS WITH ALCOHOLIC CIRRHOSIS OF THE LIVER ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE DEPENDING ON THE STAGE OF DECOMPENSATION
- Influence of Levocarnitin Treatment during a Stable Ischemic Heart Disease in Patients with Non-Alcoholic Fatty Liver Disease and Obesity
- Comprehensive Approach to Treatment of Patients with Non-Alcoholic Fatty Liver Disease
- EXPERIMENTAL RATIONALE OF THE USE OF MINERAL WATERS OF MORSHYN RESORT IN TREATMENT OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
- GEOMETRICAL MODEL OF HEART AT PATIENTS WITH NOT ALCOHOLIC FATTY ALCOHOLIC DISEASE OF THE LIVER
- Statistical Neural Networks in the Classification of Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease
- FEATURES OF ULTRASONIC PICTURE GEPATOBILIARNA OF SYSTEM AND PANCREAS AT PATIENTS WITH NOT ALCOHOLIC FATTY ALCOHOLIC DISEASE OF THE LIVER
- ESTIMATION OF LIPID PROFILE AND GLYCEMIC STATUS AND LIVER ENZYMES, AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
- Improvement of Diagnostic Algorithm in Patients With Alcoholic Fatty Liver Disease by Using Non-invasive Methods of Verification of Liver Steatosis and Fibrosis